HomeEUROPEENGLANDSEWAGE SECRETS UNCOVERED: SIX UK WATER COMPANIES FACE JUSTICE FOR FUDGING NUMBERS

SEWAGE SECRETS UNCOVERED: SIX UK WATER COMPANIES FACE JUSTICE FOR FUDGING NUMBERS

Published on

spot_img

Significant strides were made today in the first environmental class action in the United Kingdom’s history, as the Competition Appeal Tribunal (CAT) considered claims involving six water companies.

Professor Carolyn Roberts, the proposed class representative, alleges that these six companies have overcharged their customers by an amount ranging from 800 million to 1.5 billion pounds due to their significant underreporting of the actual extent of sewage pollution affecting rivers and waterways.

Roberts claims that the firms have exploited their dominant position to mislead regulatory bodies regarding the volume of sewage discharged from their facilities over the past decade. Consequently, the companies—Thames Water, Yorkshire Water, Anglian Water, Severn Trent, Northumbrian Water, and United Utilities—were able to impose inflated charges on customers, which would not have been permissible had they accurately represented the reality of their sewage pollution to the regulators.

The pricing framework overseen by Ofwat essentially creates a financial incentive for water companies to be less than forthcoming about sewage contamination, simply because they are penalized for incidents. According to the PCR, the six companies have deceived both Ofwat and the Environment Agency by underreporting the frequency of sewage discharges from their treatment facilities and combined sewer overflows since at least 2014.

By providing regulators with inaccurate information regarding the extent of sewage discharges, they were permitted by Ofwat to impose elevated charges on customers, which would not have been the case had they disclosed the sewage pollution truthfully. An analysis of data from Thames Water alone implied that the company may have neglected to report over 6,000 instances of raw sewage discharges.

Latest articles

ALLERGAN BREAST IMPLANT LAWSUITS: KEY INSIGHTS INTO THE GROWING LEGAL BATTLE

In recent years, Allergan, the Ireland-based medical device manufacturer, has found itself at the...

EU SLAPS TEVA WITH €462 MILLION FINE FOR ANTI-COMPETITIVE TACTICS IN MS DRUG MARKET

In a landmark decision, the European Commission fined Teva Pharmaceuticals 462.6 million euros for...

DUTCH COURT DISMISSES SHAREHOLDER CLAIMS AGAINST PETROBRAS

On 30 October 2024, the Rotterdam district court ruled to dismiss claims by the...

COURT OF APPEAL TO RECONSIDER USE OF CPR 19.8 IN LANDMARK DATA PRIVACY CLASS ACTION

The Court of Appeal of England and Wales is reviewing an appeal by Andrew...

More like this

ALLERGAN BREAST IMPLANT LAWSUITS: KEY INSIGHTS INTO THE GROWING LEGAL BATTLE

In recent years, Allergan, the Ireland-based medical device manufacturer, has found itself at the...

EU SLAPS TEVA WITH €462 MILLION FINE FOR ANTI-COMPETITIVE TACTICS IN MS DRUG MARKET

In a landmark decision, the European Commission fined Teva Pharmaceuticals 462.6 million euros for...

DUTCH COURT DISMISSES SHAREHOLDER CLAIMS AGAINST PETROBRAS

On 30 October 2024, the Rotterdam district court ruled to dismiss claims by the...